Big News, Money in Neurostimulation for Cognitive Decline; Pharma Not Worried
- DHV-NET
- Mar 31, 2023
- 1 min read
Cognito Therapeutics just announced a $73 million funding round to support clinical trials of their GammaSense neuromodulation treatment. Early studies showed significant slowing of cognitive decline (though not reversal).
